Safety and PK Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Stable Schizophrenia

Clinical trial NCT02411526 · COMPLETED

Trial details

NCT number: NCT02411526
Sponsor: Zogenix, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder

Start date: 2015-02-01
Primary completion: 2015-09-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.